Switcher Stories
"We like the fact that there is a similar level of robustness across all of the different applications. Also, we have always received excellent technical support and service."
"We specifically chose Illumina for our own studies because we found it to be less labor intensive, more cost effective, and accurate. The Illumina platform has allowed us to perform transcriptional profiling on an epidemiological scale that was not previously attempted."
"We also made an active decision to switch to Illumina for almost all of our genotyping needs. For high-density analysis, we believe that Illumina provides the best overall solution."
John Blangero, Ph. D.
Director of the AT&T Genomic Computing Center
Department of Genetics
Southwest Foundation for Biomedical Research
View Dr. Blangero’s interview in "Taking a Faster Approach to Genetic Discovery"